Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887414 · ClinicalTrials.gov registry record
TRIAD Appendicitis Decision-making Surveys
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 2,542
- Enrollment target
NCT05887414: Completed study, sponsored by University of Washington.
NCT05887414 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 2,542 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05887414 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 2,542 participants
- Enrollment target
Study Summary
While appendectomy has been the main treatment of appendicitis for over 100 years, recent European studies found that, at least among highly selected patients, antibiotics alone can be an effective alternative. Surgeons and patients alike have a difficult time deciding if surgery or antibiotics are the best choice to treat appendicitis. The goal of the TRIAD is to evaluate the patients who are a part of the TRIAD implementation program and assess satisfaction and decisional regret for patients with appendicitis. This information will be used to inform the design of decision-support interventions to help patients improve their ability to make an informed decision in-line with their preferences and values.
Primary Outcome
Ottawa Decisional Conflict Scale (DCS) measures personal perceptions of uncertainty in choosing options; modifiable factors contributing to uncertainty; and effective decision making
Interventions
- OTHER Baseline
- OTHER 30 Day Follow Up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,542 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2026-01-01 |
What the finished NCT05887414 record still lists
NCT05887414 is an observational study that tracks outcomes without assigning an intervention. Its 2,542 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Baseline is the first listed.
NCT05887414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05887414 about?
NCT05887414 is a clinical study titled "TRIAD Appendicitis Decision-making Surveys". While appendectomy has been the main treatment of appendicitis for over 100 years, recent European studies found that, at least among highly selected patients, antibiotics alone can be an effective alternative. Surgeons and patients alike have a difficult time deciding if surgery or antibiotics are ...
What is the current status of trial NCT05887414?
This trial is currently completed. The enrollment target is 2,542 participants. The study started on 2022-10-01. Estimated completion is 2026-01-01.
What interventions are being tested in trial NCT05887414?
The interventions under investigation include: Baseline (OTHER), 30 Day Follow Up (OTHER).
Who is sponsoring clinical trial NCT05887414?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05931276 · 2,540 participants · Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI